Hu S - Search Results

1

Clinical Significance of Plasma Epstein-Barr Virus DNA in Peripheral T-Cell Lymphomas.

Zhao D, Hu S, Zhou D, Zhang Y, Wang W, Zhang W. Zhao D, et al. Among authors: hu s. Acta Haematol. 2022;145(2):132-143. doi: 10.1159/000516588. Epub 2021 Nov 9. Acta Haematol. 2022. PMID: 34753127

2

Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.

Jia B, Hu S, Yang J, Zhou S, Liu P, Qin Y, Gui L, Yang S, Lin H, Zhang C, Xing P, Wang L, Dong M, Zhou L, Sun Y, He X, Shi Y. Jia B, et al. Among authors: hu s. Hematology. 2016 Oct;21(9):536-41. doi: 10.1080/10245332.2016.1152084. Epub 2016 Apr 6. Hematology. 2016. PMID: 27077778

3

The optimal timing of radiotherapy in the combined modality therapy for limited-stage extranodal NK/T cell lymphoma (ENKTL): a systematic review and meta-analysis.

Hu S, Zhou D, Zhang W. Hu S, et al. Ann Hematol. 2018 Dec;97(12):2279-2287. doi: 10.1007/s00277-018-3479-2. Epub 2018 Aug 20. Ann Hematol. 2018. PMID: 30128904 Review.

4

Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure.

Hu S, Song Y, Sun X, Su L, Zhang W, Jia J, Bai O, Yang S, Liang R, Li X, Zhang H, Gao Y, Zhang W, Xiao X, Bao H, Wang N, Ren H, Cen X, Yang S, Zhao Y, Wang Y, Wang Y, Liu A, Wang J, Shi Y, Yuan M, Li Y, He X. Hu S, et al. Cancer Sci. 2018 Dec;109(12):3943-3952. doi: 10.1111/cas.13828. Epub 2018 Nov 11. Cancer Sci. 2018. PMID: 30302857 Free PMC article.

5

Autoimmune disease-associated non-Hodgkin's lymphoma-a large retrospective study from China.

Hu S, Zhou D, Wu Y, Zhao Y, Wang S, Han B, Duan M, Li J, Zhu T, Zhuang J, Cao X, Cai H, Feng J, Zhang Y, Zhang F, Zeng X, Zhao Y, Wang Q, Zhang W. Hu S, et al. Ann Hematol. 2019 Feb;98(2):445-455. doi: 10.1007/s00277-018-3515-2. Epub 2018 Oct 29. Ann Hematol. 2019. PMID: 30370485

6

Circulating PD-1 (+) cells may participate in immune evasion in peripheral T-cell lymphoma and chidamide enhance antitumor activity of PD-1 (+) cells.

Zhang W, Shen H, Zhang Y, Wang W, Hu S, Zou D, Zhou D. Zhang W, et al. Among authors: hu s. Cancer Med. 2019 May;8(5):2104-2113. doi: 10.1002/cam4.2097. Epub 2019 Apr 10. Cancer Med. 2019. PMID: 30969023 Free PMC article.

7

Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas.

Qian L, Yan M, Zhang W, Zhou D, Zhang Y, Huo L, Luo Y, Zhang Y, Hu S. Qian L, et al. Among authors: hu s. Leuk Lymphoma. 2020 Apr;61(4):927-933. doi: 10.1080/10428194.2019.1697815. Epub 2019 Dec 4. Leuk Lymphoma. 2020. PMID: 31795794

8

Successful treatment with lenalidomide plus chidamide combination therapy in 3 heavily treated patients with non-Hodgkin lymphoma: Three cases report.

Hu S, Zou D, Zhou D, Zhang Y, Wang W, Zhang W. Hu S, et al. Medicine (Baltimore). 2020 Oct 23;99(43):e22788. doi: 10.1097/MD.0000000000022788. Medicine (Baltimore). 2020. PMID: 33120793 Free PMC article.

9

A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL.

Wei C, Hu S, Luo M, Chen C, Wang W, Zhang W, Zhou D. Wei C, et al. Among authors: hu s. Front Oncol. 2021 Jun 1;11:682436. doi: 10.3389/fonc.2021.682436. eCollection 2021. Front Oncol. 2021. PMID: 34141623 Free PMC article.

10

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis.

Gao H, Wu M, Hu S, Ding N, Ji X, Mi L, Wang X, Song Y, Zhu J, Liu W. Gao H, et al. Among authors: hu s. Front Oncol. 2022 Nov 17;12:1039888. doi: 10.3389/fonc.2022.1039888. eCollection 2022. Front Oncol. 2022. PMID: 36465366 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17,371 results

Search Page